Stocks · Real Estate · REIT - Healthcare Facilities
Sabra Health Care REIT, Inc. SBRA
$19.07 -0.47% Close, Oct 5, 2026 · NASDAQ · Market cap $4.83B
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to 11.8% from 37.0% a year earlier.
- Diluted EPS over the last four quarters was $0.26, down 65.5% year over year.
- Net debt is 6.7× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Real Estate sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
Growth69Positive
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 25%
- EPS growth (TTM, YoY)Bottom 18%
- FCF growth (TTM, YoY)Top 43%
- Revenue growth, 3-year CAGRTop 40%
- Revenue growth accelerationTop 16%
Quality79Positive
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 11%
- Gross marginTop 22%
- Operating marginBottom 27%
- Cash conversion (OCF / net income)Top 13%
- Accruals (lower is better)Top 23%
- Net debt / EBITDA (lower is better)Bottom 38%
- Interest coverBottom 44%
Value33Weak
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 42%
- Free-cash-flow yieldTop 36%
- EBITDA / enterprise valueBottom 32%
- Sales / enterprise valueTop 45%
- P/E vs own 5-year history (lower is better)Bottom 22%
Momentum68Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 24%
- 6-month returnBottom 46%
- 1-year return vs S&P 500Top 29%
- Distance from 52-week highTop 29%
- Trend checklist (0–4)Top 39%
Revisions11Very weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 16%
- Consecutive EPS beatsBottom 18%
- Share of analysts rating BuyBottom 33%
- Upside to consensus price targetBottom 35%
Stability67Positive
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 31%
- Maximum drawdown, 3 yearsTop 9%
- Beta vs S&P 500 (lower is better)Top 10%
- Net debt / EBITDA (lower is better)Bottom 38%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 12.9% | 17.3% | ↑ |
| EPS growth (YoY) | 7.2% | -65.5% | ↓ |
| Gross margin | 67.3% | 72.6% | ↑ |
| Operating margin | 37.0% | 11.8% | ↓ |
| FCF margin | 46.2% | 40.3% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 17.3% | 12.9% | ↑ | Top 25% |
| EPS growth (TTM, YoY) | -65.5% | 7.2% | ↓ | Bottom 18% |
| Gross margin | 72.6% | 67.3% | ↑ | Top 22% |
| Operating margin | 11.8% | 37.0% | ↓ | Bottom 27% |
| Net margin | 7.6% | 24.9% | ↓ | — |
| Free-cash-flow margin | 40.3% | 46.2% | ↓ | — |
| Return on invested capital | 23.3% | — | Top 11% | |
| Revenue growth, 3-year CAGR | 7.4% | — | Top 40% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -33.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 6.73×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 1.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 6.17%
- Net buyback yield (TTM)
- -5.20%
- Shareholder yield
- 0.97%
- Share count change, 1 year
- +4.7%
- Share count change, 3-year CAGR
- +2.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -61.6%
- Average 2-day reaction, last 8
- -0.1%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $22.57
- Target vs current price
- +18.4%
- Analysts with a rating
- 29
- Share rating Buy or Strong Buy
- 38%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | -158.4% | -2.6% | -0.6% | -2.6% | — |
| Apr 29, 2026 | -4.0% | -0.8% | -0.6% | -0.3% | +9.0% |
| Feb 12, 2026 | -35.3% | +3.3% | +2.1% | +6.0% | +5.9% |
| Nov 5, 2025 | -48.7% | +1.2% | +6.6% | +6.9% | +1.6% |
| Aug 4, 2025 | +55.6% | +0.7% | +2.4% | +4.5% | +0.3% |
| May 5, 2025 | -2.0% | -0.8% | +4.4% | +0.3% | +3.1% |
| Feb 20, 2025 | +25.0% | -1.0% | -1.0% | +6.4% | +7.3% |
| Oct 31, 2024 | -17.0% | -0.9% | -5.6% | -3.4% | -15.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.10 | $0.17 | -158.4% | $235.9M |
| Apr 29, 2026 | $0.16 | $0.17 | -4.0% | $221.8M |
| Feb 12, 2026 | $0.11 | $0.17 | -35.3% | $211.9M |
| Nov 5, 2025 | $0.09 | $0.18 | -48.7% | $190.0M |
| Aug 4, 2025 | $0.28 | $0.18 | +55.6% | $189.2M |
| May 5, 2025 | $0.17 | $0.17 | -2.0% | $183.5M |
| Feb 20, 2025 | $0.20 | $0.16 | +25.0% | $182.3M |
| Oct 31, 2024 | $0.13 | $0.16 | -17.0% | $178.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 72.7× | 39.5× | 67th | Bottom 42% |
| P/E (forward) | 40.5× | — | — | — |
| EV / EBITDA | 20.2× | — | — | Bottom 32% |
| EV / Sales | 8.43× | — | — | Top 45% |
| Free-cash-flow yield | 7.17% | — | — | Top 36% |
| Earnings yield | 1.38% | — | — | Bottom 42% |
P/E over the past five years
Range 24.2× – 239.8× since Jun 30, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +4.4%
- Earnings per share growth (TTM)
- -65.5%
- Change in P/E multiple
- +224.3%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -0.6%
- 200-day average slope (20 days)
- +0.5%
- Distance from 50-day average
- -6.9%
- Distance from 200-day average
- -4.4%
- RSI (14)
- 26.8
- Relative volume
- 1.38×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 28.6%
- Volatility vs own 5-year history
- 70th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.12
- Correlation with S&P 500
- 0.09
- Current drawdown from 1-year high
- -14.8%
- Maximum drawdown, 3 years
- -19.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 24, 2021 | Mar 23, 2023 | -45.8% | 523 days | 372 days (Sep 16, 2024) |
| Nov 11, 2024 | Feb 24, 2025 | -19.3% | 69 days | 219 days (Jan 7, 2026) |
| May 14, 2026 | Jun 4, 2026 | -16.7% | 14 days | 31 days (Jul 21, 2026) |
| Jul 27, 2026 | Oct 5, 2026 | -14.8% | 49 days | Not yet recovered |
| Oct 8, 2020 | Oct 30, 2020 | -11.7% | 16 days | 6 days (Nov 9, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $4.83B
- P/E (TTM)
- 72.7
- EPS, diluted (TTM)
- $0.26
- Revenue (TTM)
- $859.6M
- Dividend yield
- 6.29%
- 52-week range
- $17.17 – $22.77
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $569.5M | $624.8M | $647.5M | $703.2M | $774.6M |
| Gross profit | $428.3M | $462.2M | $452.3M | $476.1M | $503.5M |
| Operating income | $210.7M | $234.8M | $221.7M | $257.0M | $263.9M |
| Net income | -$113.3M | -$77.6M | $13.8M | $126.7M | $155.6M |
| EPS (diluted) | -$0.52 | -$0.34 | $0.06 | $0.54 | $0.64 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $178.0M | $182.3M | $183.5M | $189.2M | $190.0M | $211.9M | $221.8M | $235.9M |
| Net income | $29.8M | $46.7M | $40.3M | $65.5M | $22.5M | $27.2M | $40.9M | -$25.2M |
| EPS (diluted) | $0.13 | $0.19 | $0.17 | $0.27 | $0.09 | $0.11 | $0.16 | -$0.10 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $356.4M | $315.7M | $300.6M | $310.5M | $348.6M |
| Capital expenditure | -$33.6M | $0 | $0 | $0 | $0 |
| Free cash flow | $322.8M | $315.7M | $300.6M | $310.5M | $348.6M |
| Dividends paid | -$262.9M | -$277.2M | -$277.4M | -$280.1M | -$289.5M |
| Net share buybacks | $308.7M | -$4.8M | -$2.7M | $86.1M | $227.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $231.6M
- Total assets
- $5.51B
- Total liabilities
- $2.76B
- Total debt
- $2.65B
- Net debt
- $2.41B
- Shareholders’ equity
- $2.75B
As of Jun 30, 2026 (filed Aug 3, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 14, 2026 | $0.30 | Aug 31, 2026 |
| May 15, 2026 | $0.30 | May 29, 2026 |
| Feb 13, 2026 | $0.30 | Feb 27, 2026 |
| Nov 17, 2025 | $0.30 | Nov 28, 2025 |
| Aug 15, 2025 | $0.30 | Aug 29, 2025 |
| May 16, 2025 | $0.30 | May 30, 2025 |
| Feb 14, 2025 | $0.30 | Feb 28, 2025 |
| Nov 15, 2024 | $0.30 | Nov 29, 2024 |
Short interest
- Shares sold short
- 21,015,330
- Days to cover
- 9.12
- Change vs previous report
- +8.4%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 16, 2010
- 1-for-3